arctigenin has been researched along with Obesity in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Diaz, T; Elshimali, Y; Hao, Q; Henning, SM; Magyar, CE; Rettig, MB; Vadgama, JV; Verduzco, ADR; Wang, P; Zhong, J | 1 |
| Han, YH; Hong, SH; Jeon, YD; Jeong, MY; Jung, Y; Kang, J; Kee, JY; Kim, DS; Kim, HL; Kim, SJ; Lee, JH; Park, J; Park, R; Shin, S; So, HS; Um, JY; Youn, DH | 1 |
2 other study(ies) available for arctigenin and Obesity
| Article | Year |
|---|---|
Arctigenin inhibits prostate tumor growth in high-fat diet fed mice through dual actions on adipose tissue and tumor.
Topics: Adipocytes; Adipokines; Adipose Tissue; Administration, Oral; Animals; Cell Line, Tumor; Cell Proliferation; Cytokines; Diet, High-Fat; Disease Models, Animal; Dose-Response Relationship, Drug; Furans; Homeodomain Proteins; Humans; Lignans; Male; Mice; Obesity; Prostate; Prostatic Neoplasms; Receptors, Androgen; Transcription Factors; Tumor Burden; Xenograft Model Antitumor Assays | 2020 |
Arctigenin Inhibits Adipogenesis by Inducing AMPK Activation and Reduces Weight Gain in High-Fat Diet-Induced Obese Mice.
Topics: 3T3-L1 Cells; Adipocytes; Adipogenesis; AMP-Activated Protein Kinases; Animals; Dietary Fats; Enzyme Activation; Furans; Humans; Lignans; Male; Mesenchymal Stem Cells; Mice; Obesity; Weight Loss | 2016 |